Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

1.6K
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.6K
Teratogenicity01:07

Teratogenicity

4.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

705
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
705

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of the Online Portal "Embryotox" in Routine Health Care: Mixed Methods Study.

Journal of medical Internet research·2026
Same author

Anthelmintic medication with focus on first-trimester exposure: an evaluation of pregnancy outcomes based on the Embryotox cohort.

Scientific reports·2026
Same author

Standalone methacrylated extracellular matrix for digital light processing bioprinting: a practical workflow.

Frontiers in bioengineering and biotechnology·2026
Same author

Brain malformations, oxidative and nitrosative stress induced prenatally by VPA in ICR mouse fetuses are counteracted by concomitant administration of S-adenosyl methionine.

Reproductive toxicology (Elmsford, N.Y.)·2026
Same author

Cytomegalovirus in Pregnancy: Effects on the Developing Embryo and Fetus, Diagnosis and Treatment: Where to Go Now? A Narrative Review.

International journal of molecular sciences·2026
Same author

[Pharmacists' use of embryotox.de in routine healthcare].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2025
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Related Experiment Video

Updated: Mar 20, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

88.4K

Methylphenidate in Pregnancy: A Multicenter, Prospective, Comparative, Observational Study.

Orna Diav-Citrin1,2,3, Svetlana Shechtman2, Judy Arnon2

  • 1The Israeli Teratology Information Service, Israel Ministry of Health, PO Box 1176, Jerusalem, 9446724, Israel. orna.diav-citrin@moh.gov.il.

The Journal of Clinical Psychiatry
|May 28, 2016
PubMed
Summary
This summary is machine-generated.

Methylphenidate use during pregnancy did not show an increased risk for major congenital anomalies. However, methylphenidate exposure was linked to a higher rate of miscarriages, warranting further investigation into its pregnancy safety.

More Related Videos

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
13:35

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

15.4K
Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.9K

Related Experiment Videos

Last Updated: Mar 20, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

88.4K
A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
13:35

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

15.4K
Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.9K

Area of Science:

  • Obstetrics and Gynecology
  • Pharmacology
  • Teratology

Background:

  • Methylphenidate is a central nervous system stimulant prescribed for attention-deficit disorder with or without hyperactivity (ADD/ADHD).
  • Limited data exist regarding methylphenidate use during human pregnancy.
  • Evaluating pregnancy safety is crucial for medications used by women of reproductive age.

Purpose of the Study:

  • To assess the risk of major congenital anomalies following prenatal exposure to methylphenidate.
  • To compare outcomes between methylphenidate-exposed pregnancies and a control group.

Main Methods:

  • A prospective, comparative, multicenter observational study.
  • 382 methylphenidate-exposed pregnancies were compared to pregnancies with nonteratogenic exposure (NTE).
  • Matching criteria included maternal age, gestational age, and year of contact.

Main Results:

  • No significant difference in major congenital anomalies between methylphenidate and NTE groups (3.2% vs 3.6%).
  • Excluding genetic anomalies and focusing on organogenesis, rates remained similar (2.4% vs 3.4%).
  • A higher rate of miscarriages and elective terminations was observed in the methylphenidate group.

Conclusions:

  • Methylphenidate does not appear to elevate the risk of major malformations.
  • Methylphenidate exposure may be associated with an increased risk of miscarriage.
  • Further research is needed to fully establish methylphenidate's safety profile in pregnancy.